Business ❯Pharmaceuticals ❯Investment

Manufacturing

AstraZeneca Vaccines

Novartis Confirms $23 Billion U.S. Investment with Major Expansion Plans

Novartis Announces $23 Billion U.S. Expansion with New Plants and R&D Hub

AstraZeneca Cancels £450m UK Vaccine Plant Expansion Over Funding Dispute

AstraZeneca Cancels £450m UK Vaccine Plant Investment